Skip to content
Review Open access

Peripheral artery disease: Putting the updated 2024 AHA/ACC guideline into practice

Oct 2026 · Cleveland Clinic journal of medicine · Vol 93, pp. 603 - 615 · 0 citations · 28 references
Medicine

Abstract

The 2024 American Heart Association and American College of Cardiology multisociety peripheral artery disease (PAD) guideline updates the 2016 guideline by clarifying clinical terminology, using trial evidence to guide pharmacotherapy, and addressing equity and access to care. This article summarizes the main clinical recommendations and how to implement them. The new guideline, which updates the 2016 guideline, clarifies clinical terminology, applies trial evidence to pharmacotherapy and revascularization recommendations, and addresses equity and access to care.

Read PDF

Similar papers

Review Open access Oct 2026

2025 European Society of Cardiology guidelines for the management of cardiovascular disease and pregnancy

This article contextualises the 2025 European Society of Cardiology (ESC) guidelines for managing cardiovascular disease (CVD) and pregnancy in the Netherlands. The guideline addendum provides additional recommendations for situations where the ESC guidelines may not fully align with Dutch clinical practice. By endorsi...

H. B. van der Zwaan, Deborah N. Kalkman, Marjolijn J. Broekman et al. · 1 citation
Review Open access Oct 2026

Navigating medical management in chronic coronary syndrome: evidence, controversies and guideline updates.

ABSTRACT Chronic coronary syndrome (CCS), one of the top contributors to mortality and morbidity worldwide, is an emerging entity that moves beyond the traditional view of fixed, flow-limiting epicardial stenoses as the sole cause of ischaemia to encompass a broader and more heterogeneous group of conditions. This hete...

R. Soh, Aaron Kwun Hang Ho, G. Ng et al. · 0 citations
Open access Sep 2026

2025 AHA/ACC blood pressure guideline and HEARTS 2.0: implications for the future evolution of integrated cardiovascular–kidney–metabolic care in the Americas

ABSTRACT Hypertension is the leading modifiable risk factor for cardiovascular disease. In 2025, two major evidence-based frameworks evolved in parallel: HEARTS 2.0, an implementation-oriented clinical pathway for integrated cardiovascular–kidney–metabolic (CKM) care through primary health care, and the updated America...

D. DiPette, Sean J. Battle, Andrés Rosende et al. · 0 citations
Open access Sep 2026

The 2026 ESC heart failure guidelines: advancing science while facilitating clinical implementation

The 2026 European Society of Cardiology (ESC) guidelines for the management of heart failure introduce a series of important changes intended to simplify classification, accelerate implementation of effective therapies, and shift care toward earlier prevention and intervention. Among the most notable changes are the in...

M. Fu, G. Savarese, Karl Swedberg · 0 citations
Open access Oct 2026

2026 Asia Pacific Heart Rhythm Society (APHRS) Guidelines (Part I) on Epidemiology, Detection/Screening and Integrated Patient Care in Atrial Fibrillation

ABSTRACT The 2026 Asia Pacific Heart Rhythm Society (APHRS) Guidelines represent the first comprehensive APHRS guidelines dedicated to the management of atrial fibrillation (AF) and comprise four parts covering epidemiology, detection/screening and integrated care; stroke prevention; rate and rhythm control; and lifest...

B. Joung, R. Krittayaphong, Yu-Tao Guo et al. · 0 citations
Review Open access Nov 2026

KDOQI Commentary on the 2025 AHA/ACC Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults.

This KDOQI commentary focuses on recommendations from the AHA/ACC guideline that are pertinent to individuals at risk of CKD or with non-dialysis-dependent CKD (stages 1-5), hence excluding commentary on hypertension management in patients receiving maintenance dialysis.

T. Chang, Jennifer L. Cluett, D. Cohen et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.